Salacia reticulata improves serum lipid profiles and glycemic control in patients with prediabetes and mild to moderate hyperlipidemia: a double-blind, placebo-controlled, randomized trial.

摘要: Abstract The present randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of Salacia reticulata leaves root bark extracts in 29 patients with prediabetes mild to moderate hyperlipidemia. Patients received either (500 mg/day) or placebo along therapeutic lifestyle changes for a period 6 weeks. Efficacy was terms change lipid profile glycemic levels. tolerability by physical examination clinical laboratory evaluations. Improvements profiles levels were observed extract-treated groups when compared at week 6. A statistical significant reduction low-density lipoprotein cholesterol fasting blood sugar (FBS) 3 treated extract. group showed statistically FBS only. No adverse events occurred all parameters were...